Altered dopamine ontogeny in the developmentally vitamin D deficient rat and its relevance to schizophrenia
暂无分享,去创建一个
[1] J. Jolles,et al. The Neuropsychology of Schizophrenia , 2019 .
[2] R. Fricker,et al. Calcitriol Imparts Neuroprotection In Vitro to Midbrain Dopaminergic Neurons by Upregulating GDNF Expression , 2013, PloS one.
[3] D. Eyles,et al. The vitamin D receptor in dopamine neurons; its presence in human substantia nigra and its ontogenesis in rat midbrain , 2013, Neuroscience.
[4] Karly M. Turner,et al. Cognitive performance and response inhibition in developmentally vitamin D (DVD)-deficient rats , 2013, Behavioural Brain Research.
[5] H. Möller,et al. Impulsivity is related to striatal dopamine transporter availability in healthy males , 2013, Psychiatry Research: Neuroimaging.
[6] A. Goodchild,et al. Catecholamine receptors differentially mediate impulsive choice in the medial prefrontal and orbitofrontal cortex , 2013, Journal of psychopharmacology.
[7] A. Björklund,et al. α-Synuclein–Induced Down-Regulation of Nurr1 Disrupts GDNF Signaling in Nigral Dopamine Neurons , 2012, Science Translational Medicine.
[8] R. Murray,et al. Volumetric abnormalities predating the onset of schizophrenia and affective psychoses: an MRI study in subjects at ultrahigh risk of psychosis. , 2012, Schizophrenia bulletin.
[9] Mark Slifstein,et al. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. , 2012, Archives of general psychiatry.
[10] D. Eyles,et al. Developmental vitamin D deficiency alters MK-801-induced behaviours in adult offspring , 2012, Psychopharmacology.
[11] I. Weiner,et al. Tracing the development of psychosis and its prevention: What can be learned from animal models , 2012, Neuropharmacology.
[12] Stephan Ripke,et al. Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs , 2012, Nature Genetics.
[13] J. Feldon,et al. Schizophrenia: do all roads lead to dopamine or is this where they start? Evidence from two epidemiologically informed developmental rodent models , 2012, Translational Psychiatry.
[14] F. Turkheimer,et al. Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. , 2011, The American journal of psychiatry.
[15] E. Susser,et al. Age at migration and future risk of psychotic disorders among immigrants in the Netherlands: a 7-year incidence study. , 2011, The American journal of psychiatry.
[16] R. Murray,et al. Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study , 2011, Molecular Psychiatry.
[17] A. Mechelli,et al. Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study. , 2011, Archives of general psychiatry.
[18] R. Murray,et al. Striatal dopamine synthesis capacity in twins discordant for schizophrenia , 2011, Psychological Medicine.
[19] S. Yılmazer,et al. The Effects of Vitamin D Receptor Silencing on the Expression of LVSCC-A1C and LVSCC-A1D and the Release of NGF in Cortical Neurons , 2011, PloS one.
[20] D. Eyles,et al. Developmental vitamin D (DVD) deficiency alters pup-retrieval but not isolation-induced pup ultrasonic vocalizations in the rat , 2011, Physiology & Behavior.
[21] B. Cong,et al. Expression of Nurr1 during rat brain and spinal cord development , 2011, Neuroscience Letters.
[22] Sang-Hun Lee,et al. Retinoid X receptor &agr; acts as a negative regulator in Nurr1-induced dopaminergic differentiation in rat neural precursor cells , 2010, Neuroreport.
[23] D. Eyles,et al. Maternal vitamin D deficiency alters the expression of genes involved in dopamine specification in the developing rat mesencephalon , 2010, Neuroscience Letters.
[24] J. McGrath,et al. NEONATAL VITAMIN D STATUS AND RISK OF SCHIZOPHRENIA: A POPULATION-BASED CASE-CONTROL STUDY , 2010, Schizophrenia Research.
[25] U. Meyer,et al. A LONGITUDINAL EXAMINATION OF THE NEURODEVELOPMENTAL IMPACT OF PRENATAL IMMUNE ACTIVATION IN MICE REVEALS PRIMARY DEFECTS IN DOPAMINERGIC DEVELOPMENT RELEVANT TO SCHIZOPHRENIA , 2010, Schizophrenia Research.
[26] D. Eyles,et al. Developmental vitamin D deficiency alters dopamine turnover in neonatal rat forebrain , 2009, Neuroscience Letters.
[27] U. Meyer,et al. In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders , 2009, Neuroscience & Biobehavioral Reviews.
[28] M. Laruelle,et al. Baseline and Amphetamine-Stimulated Dopamine Activity Are Related in Drug-Naïve Schizophrenic Subjects , 2009, Biological Psychiatry.
[29] S. Rutz,et al. The modulation of striatal dopamine release correlates with water-maze performance in aged rats , 2009, Neurobiology of Aging.
[30] S. Kapur,et al. The dopamine hypothesis of schizophrenia: version III--the final common pathway. , 2009, Schizophrenia bulletin.
[31] P. Mortensen,et al. A sensitive LC/MS/MS assay of 25OH vitamin D3 and 25OH vitamin D2 in dried blood spots. , 2009, Clinica chimica acta; international journal of clinical chemistry.
[32] J. Feldon,et al. Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia. , 2009, The international journal of neuropsychopharmacology.
[33] A. Carlsson,et al. EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. , 2009, Acta pharmacologica et toxicologica.
[34] Robin M. Murray,et al. Schizophrenia: From developmental deviance to dopamine dysregulation , 2008, European Neuropsychopharmacology.
[35] T. Hare,et al. The Adolescent Brain , 2008, Annals of the New York Academy of Sciences.
[36] Kilian M. Pohl,et al. Neocortical Gray Matter Volume in First-Episode Schizophrenia and First-Episode Affective Psychosis: A Cross-Sectional and Longitudinal MRI Study , 2007, Biological Psychiatry.
[37] A. Mackay-Sim,et al. Maternal vitamin D depletion alters neurogenesis in the developing rat brain , 2007, International Journal of Developmental Neuroscience.
[38] D. Eyles,et al. Vitamin D deficiency during various stages of pregnancy in the rat; its impact on development and behaviour in adult offspring , 2007, Psychoneuroendocrinology.
[39] S. Nicola. The nucleus accumbens as part of a basal ganglia action selection circuit , 2007, Psychopharmacology.
[40] R. Murray,et al. Risk factors for schizophrenia — All roads lead to dopamine , 2007, European Neuropsychopharmacology.
[41] J. Suckling,et al. Cerebral grey, white matter and csf in never-medicated, first-episode schizophrenia , 2007, Schizophrenia Research.
[42] P. Grasby,et al. The pre-synaptic dopaminergic system before and after the onset of psychosis: initial results , 2006, European Neuropsychopharmacology.
[43] D. Eyles,et al. Hyperlocomotion associated with transient prenatal vitamin D deficiency is ameliorated by acute restraint , 2006, Behavioural Brain Research.
[44] J. Rapoport,et al. Childhood onset schizophrenia: cortical brain abnormalities as young adults. , 2006, Journal of child psychology and psychiatry, and allied disciplines.
[45] A. Caspi,et al. Neuropsychological performance at the age of 13 years and adult schizophreniform disorder: prospective birth cohort study. , 2006, The British journal of psychiatry : the journal of mental science.
[46] D. Eyles,et al. Developmental Vitamin D Deficiency Alters MK 801-Induced Hyperlocomotion in the Adult Rat: An Animal Model of Schizophrenia , 2006, Biological Psychiatry.
[47] D. Eyles,et al. Developmental vitamin D (DVD) deficiency in the rat alters adult behaviour independently of HPA function , 2006, Psychoneuroendocrinology.
[48] J. Palha,et al. Thyroid hormones and retinoids: A possible link between genes and environment in schizophrenia , 2006, Brain Research Reviews.
[49] K. Hashimoto,et al. Immune Activation During Pregnancy in Mice Leads to Dopaminergic Hyperfunction and Cognitive Impairment in the Offspring: A Neurodevelopmental Animal Model of Schizophrenia , 2006, Biological Psychiatry.
[50] S. Dunnett,et al. Re‐examining the ontogeny of substantia nigra dopamine neurons , 2006, The European journal of neuroscience.
[51] E. Kandel,et al. Transient and Selective Overexpression of Dopamine D2 Receptors in the Striatum Causes Persistent Abnormalities in Prefrontal Cortex Functioning , 2006, Neuron.
[52] D. Eyles,et al. Transient prenatal vitamin D deficiency is associated with subtle alterations in learning and memory functions in adult rats , 2005, Behavioural Brain Research.
[53] A. Mackay-Sim,et al. Developmental Vitamin D3 deficiency alters the adult rat brain , 2005, Brain Research Bulletin.
[54] J. McGrath,et al. Distribution of the Vitamin D receptor and 1α-hydroxylase in human brain , 2005, Journal of Chemical Neuroanatomy.
[55] B. Glenthøj,et al. Disruption of Neurogenesis on Gestational Day 17 in the Rat Causes Behavioral Changes Relevant to Positive and Negative Schizophrenia Symptoms and Alters Amphetamine-Induced Dopamine Release in Nucleus Accumbens , 2004, Neuropsychopharmacology.
[56] D. Eyles,et al. Maternal vitamin D3 deprivation and the regulation of apoptosis and cell cycle during rat brain development. , 2004, Brain research. Developmental brain research.
[57] A. Mackay-Sim,et al. Transient prenatal Vitamin D deficiency is associated with hyperlocomotion in adult rats , 2004, Behavioural Brain Research.
[58] R. Burke. Ontogenic cell death in the nigrostriatal system , 2004, Cell and Tissue Research.
[59] G. Laviola,et al. Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model , 2004, Behavioural pharmacology.
[60] C. Perrone-Capano,et al. Modulation of nurr1 gene expression in mesencephalic dopaminergic neurones , 2004, Journal of neurochemistry.
[61] Peter B. Jones,et al. Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study , 2004, Schizophrenia Research.
[62] R. Burke,et al. Regulation of the Development of Mesencephalic Dopaminergic Systems by the Selective Expression of Glial Cell Line-Derived Neurotrophic Factor in Their Targets , 2004, The Journal of Neuroscience.
[63] E. Arenas,et al. Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells. , 2003, Genes & development.
[64] B. Joseph,et al. p57Kip2 cooperates with Nurr1 in developing dopamine cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[65] P. Banerjee,et al. Antiproliferative role of vitamin D and its analogs – a brief overview , 2003, Molecular and Cellular Biochemistry.
[66] H. Hoeger,et al. Neurodegeneration, Neuronal Loss, and Neurotransmitter Changes in the Adult Guinea Pig with Perinatal Asphyxia , 2003, Pediatric Research.
[67] D. Eyles,et al. Vitamin D receptor expression in the embryonic rat brain , 2003 .
[68] R. Burke,et al. Regulation of Natural Cell Death in Dopaminergic Neurons of the Substantia Nigra by Striatal Glial Cell Line-Derived Neurotrophic Factor In Vivo , 2003, The Journal of Neuroscience.
[69] Kwang-Soo Kim,et al. Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell‐specific manner , 2003, Journal of neurochemistry.
[70] V. Chefer,et al. Enhanced Responsiveness to Novelty and Cocaine Is Associated with Decreased Basal Dopamine Uptake and Release in the Nucleus Accumbens: Quantitative Microdialysis in Rats under Transient Conditions , 2003, The Journal of Neuroscience.
[71] S. Andersen. Trajectories of brain development: point of vulnerability or window of opportunity? , 2003, Neuroscience & Biobehavioral Reviews.
[72] B. El-Khodor,et al. Birth insult interacts with stress at adulthood to alter dopaminergic function in animal models: possible implications for schizophrenia and other disorders , 2003, Neuroscience & Biobehavioral Reviews.
[73] P. Dhawan,et al. New insights into the mechanisms of vitamin D action , 2003, Journal of cellular biochemistry.
[74] Neal R. Swerdlow,et al. Dopamine agonists disrupt visual latent inhibition in normal males using a within-subject paradigm , 2003, Psychopharmacology.
[75] T. Perlmann,et al. Defining Requirements for Heterodimerization between the Retinoid X Receptor and the Orphan Nuclear Receptor Nurr1* , 2002, The Journal of Biological Chemistry.
[76] J. Barsony,et al. Retinoid X receptor dominates the nuclear import and export of the unliganded vitamin D receptor. , 2002, Molecular endocrinology.
[77] R. Balling,et al. Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. , 2002, Molecular endocrinology.
[78] Richie Poulton,et al. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. , 2002, Archives of general psychiatry.
[79] B. Volpe,et al. Marked Dopaminergic Cell Loss Subsequent to Developmental, Intranigral Expression of Glial Cell Line-Derived Neurotrophic Factor , 2002, Experimental Neurology.
[80] L. Olson,et al. Orphan Nuclear Receptor Nurr1 Is Essential for Ret Expression in Midbrain Dopamine Neurons and in the Brain Stem , 2001, Molecular and Cellular Neuroscience.
[81] C. Tamminga,et al. Effects of Ketamine in Normal and Schizophrenic Volunteers , 2001, Neuropsychopharmacology.
[82] Daniel R Weinberger,et al. Delayed onset of enhanced MK-801-induced motor hyperactivity after neonatal lesions of the rat ventral hippocampus , 2001, Biological Psychiatry.
[83] A. Parisi,et al. Vitamin D insufficiency in south‐east Queensland , 2001, The Medical journal of Australia.
[84] A. Howie,et al. Extrarenal Expression of 25-Hydroxyvitamin D3-1α-Hydroxylase1 , 2001 .
[85] Y. Smith,et al. Anatomy of the dopamine system in the basal ganglia , 2000, Trends in Neurosciences.
[86] T. Iwawaki,et al. Identification of a potential nurr1 response element that activates the tyrosine hydroxylase gene promoter in cultured cells. , 2000, Biochemical and biophysical research communications.
[87] B. Turetsky,et al. Temporolimbic volume reductions in schizophrenia. , 2000, Archives of general psychiatry.
[88] S. Kapur,et al. Schizophrenia: more dopamine, more D2 receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[89] L. Spear. The adolescent brain and age-related behavioral manifestations , 2000, Neuroscience & Biobehavioral Reviews.
[90] T. Hayashi,et al. Vitamin D3 attenuates cortical infarction induced by middle cerebral arterial ligation in rats , 2000, Neuropharmacology.
[91] J. Mcgrath. Hypotheses: Is low prenatal vitamin D a risk-modifying factor for schizophrenia? , 2000, Schizophrenia Research.
[92] J. Mcgrath. Hypothesis: Is low prenatal vitamin D a risk-modifying factor for schizophrenia? , 1999, Schizophrenia Research.
[93] L. Olson,et al. Fate of mesencephalic AHD2-expressing dopamine progenitor cells in NURR1 mutant mice. , 1999, Experimental cell research.
[94] R. Murray,et al. The developmental 'risk factor' model of schizophrenia. , 1999, Journal of psychiatric research.
[95] F. Gage,et al. Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. , 1999, Development.
[96] P. Andiné,et al. Characterization of MK-801-induced behavior as a putative rat model of psychosis. , 1999, The Journal of pharmacology and experimental therapeutics.
[97] M. Laruelle,et al. Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies , 1999, Journal of psychopharmacology.
[98] M. Laruelle,et al. Increased dopamine transmission in schizophrenia: relationship to illness phases , 1999, Biological Psychiatry.
[99] T. Veenstra,et al. Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord , 1999, Journal of Chemical Neuroanatomy.
[100] G. Gerhardt,et al. Age-related changes in the capacity, rate, and modulation of dopamine uptake within the striatum and nucleus accumbens of Fischer 344 rats: an in vivo electrochemical study. , 1999, The Journal of pharmacology and experimental therapeutics.
[101] R. Kumar,et al. The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators. , 1998, Biochemical and biophysical research communications.
[102] S. Brimijoin,et al. 1,25-Dihydroxyvitamin D3 receptors in the central nervous system of the rat embryo , 1998, Brain Research.
[103] M. Laruelle. Imaging dopamine transmission in schizophrenia. A review and meta-analysis. , 1998, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.
[104] J. Krystal,et al. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. , 1998, The American journal of psychiatry.
[105] A. Cools,et al. The neurodevelopment hypothesis of Schizophrenia: Clinical evidence and animal models , 1998 .
[106] R. Wightman,et al. Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter , 1998, The Journal of Neuroscience.
[107] W. Miller,et al. Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. , 1997, Molecular endocrinology.
[108] R. Yolken,et al. Seasonality of births in schizophrenia and bipolar disorder: a review of the literature , 1997, Schizophrenia Research.
[109] E. Torrey,et al. Urban birth and residence as risk factors for psychoses: an analysis of 1880 data , 1997, Schizophrenia Research.
[110] Martin H. Teicher,et al. Sex differences in dopamine receptor overproduction and elimination , 1997, Neuroreport.
[111] B J Hoffer,et al. Dopamine neuron agenesis in Nurr1-deficient mice. , 1997, Science.
[112] S. Hirsch,et al. A Pivotal Role for Glutamate in the Pathogenesis of Schizophrenia, and Its Cognitive Dysfunction , 1997, Pharmacology Biochemistry and Behavior.
[113] A. Malhotra,et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[114] R. Burke,et al. The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra. , 1997, Brain research. Developmental brain research.
[115] A Rowe,et al. Retinoid X receptors. , 1997, The international journal of biochemistry & cell biology.
[116] J. Krystal,et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[117] K. Umesono,et al. The nuclear receptor superfamily: The second decade , 1995, Cell.
[118] J. Olney,et al. Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.
[119] M. Holick,et al. Regular use of sunscreen on vitamin D levels. , 1995, Archives of dermatology.
[120] N. Andreasen,et al. Symptoms, signs, and diagnosis of schizophrenia , 1995, The Lancet.
[121] M. Feenstra,et al. Novelty-induced increase in dopamine release in the rat prefrontal cortex in vivo: inhibition by diazepam , 1995, Neuroscience Letters.
[122] T. Perlmann,et al. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. , 1995, Genes & development.
[123] P. Kalivas,et al. The role of mesoaccumbens-pallidal circuitry in novelty-induced behavioral activation , 1995, Neuroscience.
[124] A Sacker,et al. Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11 , 1994, BMJ.
[125] J. Krystal,et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.
[126] Z. Kruk,et al. Differential action of (+)‐amphetamine on electrically evoked dopamine overflow in rat brain slices containing corpus striatum and nucleus accumbens , 1994, British journal of pharmacology.
[127] S. Narayanan,et al. The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK801 , 1993, Pharmacology Biochemistry and Behavior.
[128] J. Lile,et al. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. , 1993, Science.
[129] G. Breese,et al. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats. , 1993, The Journal of pharmacology and experimental therapeutics.
[130] D. Sulzer,et al. Amphetamine and Other Weak Bases Act to Promote Reverse Transport of Dopamine in Ventral Midbrain Neurons , 1993, Journal of neurochemistry.
[131] M. Somerville,et al. Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. , 1992, Brain research. Molecular brain research.
[132] K. Davis,et al. Dopamine in schizophrenia: a review and reconceptualization. , 1991, The American journal of psychiatry.
[133] K. Andersson,et al. Asphyctic lesion: proliferation of tyrosine hydroxylase-immunoreactive nerve cell bodies in the rat substantia nigra and functional changes in dopamine neurotransmission , 1991, Brain Research.
[134] H. Groenewegen,et al. The pre- and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat , 1988, Neuroscience.
[135] M. Haussler,et al. Immunocytochemical localization of the 1,25-dihydroxyvitamin D3 receptor in target cells. , 1988, Endocrinology.
[136] R. Murray,et al. Is schizophrenia a neurodevelopmental disorder? , 1987, British medical journal.
[137] D. Weinberger. Implications of normal brain development for the pathogenesis of schizophrenia. , 1987, Archives of general psychiatry.
[138] B. Westerink. Sequence and significance of dopamine metabolism in the rat brain , 1985, Neurochemistry International.
[139] B. Angrist,et al. CNS stimulants as tools in the study of schizophrenia , 1984, Trends in Neurosciences.
[140] J. Adams,et al. INCREASED SKIN PIGMENT REDUCES THE CAPACITY OF SKIN TO SYNTHESISE VITAMIN D3 , 1982, The Lancet.
[141] Y. Nomura,et al. Ontogenetic development of high potassium- and acetylcholine-induced release of dopamine from striatal slices of the rat. , 1981, Brain research.
[142] S H Snyder,et al. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs , 1976, Science.
[143] F. Bloom,et al. Ontogeny of monoamine neurons in the locus coeruleus, raphe nuclei and substantia nigra of the rat , 1975, The Journal of comparative neurology.
[144] P. Seeman,et al. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. , 1975, Science.
[145] F. Bloom,et al. Ontogeny of monoamine neurons in the locus coeruleus, raphe nuclei and substantia nigra of the rat. I. Cell differentiation , 1974, The Journal of comparative neurology.
[146] D. Janowsky,et al. Provocation of schizophrenic symptoms by intravenous administration of methylphenidate. , 1973, Archives of general psychiatry.
[147] H. Pols,et al. Vitamin D , 1928, Calcified Tissue International.
[148] D. Rosielle,et al. Psychiatry , 1905, NeuroImage.
[149] A. Meyer-Lindenberg,et al. Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies. , 2013, Schizophrenia bulletin.
[150] D. Eyles,et al. Developmental vitamin D deficiency alters dopamine-mediated behaviors and dopamine transporter function in adult female rats , 2009, Psychopharmacology.
[151] Marie-Claude Asselin,et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. , 2009, Archives of general psychiatry.
[152] J. Feldon,et al. Relative Prenatal and Postnatal Maternal Contributions to Schizophrenia-Related Neurochemical Dysfunction after In Utero Immune Challenge , 2008, Neuropsychopharmacology.
[153] B. Casey,et al. The adolescent brain. , 2008, Developmental review : DR.
[154] M. Smidt,et al. How to make a mesodiencephalic dopaminergic neuron , 2007, Nature Reviews Neuroscience.
[155] O. Paulson,et al. Structural brain abnormalities in early onset first-episode psychosis , 2006, Journal of Neural Transmission.
[156] A. Carlsson,et al. The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice , 2005, Journal of Neural Transmission.
[157] E. Cantor-Graae,et al. Schizophrenia and migration: a meta-analysis and review. , 2005, The American journal of psychiatry.
[158] Steven A. Smith,et al. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. , 2005, Journal of chemical neuroanatomy.
[159] J. Lieberman,et al. Provocative tests with psychostimulant drugs in schizophrenia , 2004, Psychopharmacology.
[160] E. Torrey,et al. A systematic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia. , 2003, Schizophrenia bulletin.
[161] John Suckling,et al. For personal use. Only reproduce with permission from The Lancet Publishing Group. Effect of sunlight and season on serotonin turnover in the brain , 2002 .
[162] P M Stewart,et al. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. , 2001, The Journal of clinical endocrinology and metabolism.
[163] R. Lubow,et al. Latent inhibition in humans: data, theory, and implications for schizophrenia. , 1995, Psychological bulletin.
[164] P. Goldman-Rakic,et al. Synaptic development of the cerebral cortex: implications for learning, memory, and mental illness. , 1994, Progress in brain research.
[165] L. DeLisi. The significance of age of onset for schizophrenia. , 1992, Schizophrenia bulletin.
[166] E. Walker,et al. Intelligence in schizophrenia: meta-analysis of the research. , 1984, Schizophrenia bulletin.